CEACAM5 Antikörper (N-Term)
Kurzübersicht für CEACAM5 Antikörper (N-Term) (ABIN2792987)
Target
Alle CEACAM5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 50-77, N-Term
-
Verwendungszweck
- Rabbit Anti-Human CEACAM (N-term) Antibody
-
Immunogen
- This CEACAM antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 50-77 amino acids from the N-terminal region of human CEACAM.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
-
Western Blot, Immunohistochemistry, Flow Cytometry
Recommended Dilutions
WB: 1:1000, IHC: 1:10-50, FC: 1:10-50Western blot analysis of CEACAM antibody (N-term) . FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 2.0 mg/mL
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- 2-8°C (short-term), -20°C (long-term)
-
-
- CEACAM5 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5))
-
Andere Bezeichnung
- CEACAM
-
Hintergrund
-
Target Description: CEACAM is a member of the carcinoembryonic antigen (CEA) family, which belongs to the immunoglobulin superfamily. The protein was originally described in bile ducts of liver as biliary glycoprotein. Subsequently, it was found to be a cell-cell adhesion molecule detected on leukocytes, epithelia, and endothelia. The protein mediates cell adhesion via homophilic as well as heterophilic binding to other proteins of the subgroup. Multiple cellular activities have been attributed to the protein, including roles in the differentiation and arrangement of tissue three-dimensional structure, angiogenesis, apoptosis, tumor suppression, metastasis, and the modulation of innate and adaptive immune responses.
Gene Symbol: CEACAM1
-
Molekulargewicht
- 57560 Da
-
Gen-ID
- 634
-
UniProt
- P13688
Target
-